Skip to main content

Table 2 Logistic regression of COVID-19 diagnosis on comorbidity

From: Comorbidities associated with the severity of COVID-19, and differences across ethnic groups: a UK Biobank cohort study

 

Model 1 (unadjusted)

n = 472,182

Model 2 (covariates)a

n = 394974c

Model 3 (covariates and comorbidities)b

n = 396,642

Coronary Heart Disease

1.174 (1.121–1.230)

1.276 (1.209—1.347)

1.153 (1.091 – 1.218)

Hypertension

1.060 (1.035 – 1.086)

1.145 (1.112 – 1.179)

1.080 (1.047 – 1.113)

Type II Diabetes Mellitus

1.521 (1.462 – 1.582)

1.427 (1.360 – 1.497)

1.321 (1.257 – 1.387)

Obesity

1.341 (1.308 – 1.375)

1.258 (1.223 – 1.294)

1.163 (1.129 – 1.198)

Chronic Kidney Disease

1.531 (1.453 – 1.613)

1.717 (1.614 – 1.826)

1.544 (1.450 – 1.645)

Depression

1.309 (1.262 – 1.358)

1.179 (1.131 – 1.229)

1.097 (1.050– 1.147)

Anxiety

1.334 (1.272 – 1.400)

1.272 (1.204 – 1.343)

1.162 (1.097 – 1.231)

  1. Data presented as Odds Ratio (95% Confidence interval)
  2. All P values < 0.001
  3. aModel 2 was adjusted for ethnicity, sex, age, BMI, Townsend deprivation index, smoking status, qualifications, and pre-tax household income
  4. bModel 3 was adjusted for the same covariates as Model 2 (bar BMI) plus the following comorbidities: coronary heart disease, hypertension, type II diabetes mellitus, obesity, chronic kidney disease, depression, and anxiety
  5. cn for obesity = 396,642 due to the exclusion of BMI variable
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us